About ChatCME
Mission: Help accredited CME providers deliver trusted, verifiable learning and clear evidence of impact.
Who we are
ChatCME is built by Erudio Health, a healthcare technology company operating since 2023. Our work has always been in healthcare. We design software that respects independence, protects privacy, and makes outcomes measurable.
Why we are trusted
We build AI that stays within the activity, answers with citations, and reports outcomes clearly. Providers use ChatCME to embed an assistant, govern quality in an admin console, and share de-identified knowledge-gap insights with supporters.
Leadership
Audun Utengen
Co-founder
Healthcare technology and analytics across providers, medical societies, and life sciences. Co-founded Symplur and led product and customer programs.
Thomas M. Lee
Co-founder
Decades in healthcare business and analytics. Co-founded Symplur and serves as a Partner at The Fox Group, advising organizations on HIPAA compliance and independent review services.
Independence and compliance
We support independent medical education. Accredited providers control content and scope. Supporters receive aggregated, de-identified insights only.
- •Tenant isolation
- •Encryption in transit and at rest
- •Role-based access control and audit logs
- •SOC 2 aligned
- •Sign BAAs when HIPAA applies
Who uses ChatCME
We work with leading CME providers, specialty societies, and conference organizers, including one of the largest global CME publishers.
Our history and publications
June 2023
We introduced MedAffairsGPT as an early public AI-chat pilot during ASCO 2023. The pilot tested activity-scoped retrieval, citation-first responses, and conservative behavior when evidence was insufficient. These lessons shaped ChatCME’s current guardrails and citation standards.
January 2025
We launched ChatCME, purpose-built for accredited CME providers. The initial release supported embedded assistants for individual CME programs on provider sites and apps, and kiosk solutions for program collections at medical conferences. From day one, the platform emphasized outcomes analytics and de-identified knowledge-gap insights.
See our publications and our larger academic impact.
Selected highlights
- •Co-founded and operated Symplur for over a decade; acquired by Real Chemistry.
- •Created Symplur Signals, the Healthcare Social Graph, and the Healthcare Hashtags Project.
- •Invited to the White House for the Precision Medicine Initiative.
- •Collaborations with agencies and institutions such as NIH (for example NCI, NLM, NIAID), Stanford Medicine X, Mayo Clinic, and Health Datapalooza.
- •Work cited in 500+ academic publications and books, including studies in JAMA Oncology and The BMJ.
- •Community adoption across global institutions and journals through the Hashtags Project (for example WHO, EU, NHS, HHS, CMS, CDC, ESMO, ASCO, ASH, ESC, AHA, ACC, AACR, NEJM, JAMA, BMJ, The Lancet).
Timeline
Ready to learn more?
We serve accredited CME providers and their partners. Request a demo and we will arrange a tailored walkthrough.
Request a demo